Form 8-K

8-K — Cellectar Biosciences, Inc.

Accession: 0001104659-26-082719

Filed: 2026-07-10

Period: 2026-07-07

CIK: 0001279704

SIC: 2834 (PHARMACEUTICAL PREPARATIONS)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Submission of Matters to a Vote of Security Holders

Item: Financial Statements and Exhibits

Documents

8-K — tm2620219d1_8k.htm (Primary)

EX-10.1 — EXHIBIT 10.1 (tm2620219d1_ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2620219d1_8k.htm · Sequence: 1

false

0001279704

2026-07-07

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

July 7, 2026

Cellectar Biosciences, Inc.

(Exact name of Registrant as Specified in its

Charter)

Delaware

1-36598

04-3321804

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

100

Campus Drive, Florham Park, NJ, 07932

(Address of principal executive offices) (Zip

Code)

Registrant’s telephone number, including

area code: (608) 441-8120

N/A

(Former Name or Former Address, if Changed

Since Last Report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see

General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities

Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange

Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under

the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under

the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange

on which registered

Common

Stock, par value $0.00001 per share

CLRB

The Nasdaq

Capital Market

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange

Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ¨

If an emerging growth company, indicate by check mark if the registrant

has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant

to Section 13(a) of the Exchange Act.  ¨

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As described in Item 5.07 below, on July 7, 2026, at the 2026 Annual

Meeting of Stockholders (the “Annual Meeting”) of Cellectar Biosciences, Inc. (the “Company”), the Company’s

stockholders approved an amendment to the Company’s 2021 Stock Incentive Plan (the “Plan”) to increase the number of

shares reserved for issuance under the Plan by 2,000,000 shares.

A copy of the Plan, as amended, is filed as Exhibit 10.1 to this Current

Report and is incorporated by reference in this Item 5.02.

Item 5.07.

Submission of Matters to a Vote of Security Holders

The Company held the Annual Meeting at 10:00 a.m., local time, on July

7, 2026.

The proposals presented for stockholder approval at the Annual Meeting

are described below:

Proposal No. 1 – Election of Directors

Class III directors, Andrew Gu and Douglas J. Swirsky, were nominated

and elected to serve three-year terms. The vote was as follows:

Nominee

For

Withhold

Broker Non-Votes

Adnrew Gu

2,134,395

25,493

1,382,976

Douglas J. Swirsky

2,126,590

33,298

1,382,976

Proposal No. 2 – Approval of an Increase in the Number of

Shares Available for Issuance Under the 2021 Stock Incentive Plan

The Company requested approval of an increase in the number of shares

of common stock available for issuance under the Plan by 2,000,000 shares. The stockholders approved the proposal. The vote was as follows:

For

Against

Abstain

Broker Non-Votes

1,706,640

439,422

13,825

1,382,977

Proposal No. 3 – Ratification of Appointment of Independent

Registered Public Accounting Firm

The Company requested ratification of the appointment

by the Audit Committee of the Board of Directors of Deloitte & Touche LLP to be the Company’s independent registered public

accounting firm for fiscal year 2026. The stockholders ratified the appointment. The vote was as follows:

For

Against

Abstain

3,518,084

13,956

10,824

Proposal No. 4 – Approval of Executive Officer Compensation

The Company requested approval, on a non-binding

advisory basis, of the compensation of the Company’s named executive officers. The stockholders approved the compensation of the

named executive officers. The vote was as follows:

For

Against

Abstain

Broker Non-Votes

1,438,422

712,362

9,102

1,382,978

Proposal No. 5 – Approval of Exercise of Warrants

The Company requested approval the exercise

of warrants issued by the Company to purchase up to an aggregate of 39,618,078 shares of common stock under applicable rules and

regulations of the Nasdaq Stock Market LLC (the “Warrant Exercise Proposal”). The stockholders approved the proposal.

The vote was as follows:

For

Against

Abstain

Broker Non-Votes

1,881,936

55,004

222,946

1,382,977

Proposal No. 6 – Adjournment of Annual Meeting

Because the Warrant Exercise Proposal was approved,

the sixth proposal on the agenda regarding adjournment of the Annual Meeting was rendered moot and was not presented.

Item 9.01.

Financial Statements and Exhibits

(d) Exhibits

Number

Title

10.1

Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended

104

Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CELLECTAR BIOSCIENCES, INC.

Date: July 10, 2026

By:

/s/ Chad J. Kolean

Name:

Chad J. Kolean

Title:

Chief Financial Officer

EX-10.1 — EXHIBIT 10.1

EX-10.1

Filename: tm2620219d1_ex10-1.htm · Sequence: 2

Exhibit 10.1

CELLECTAR BIOSCIENCES, INC.

2021 STOCK INCENTIVE PLAN, AS AMENDED

SECTION 1. General Purpose of the Plan; Definitions

The purpose of this 2021 Stock Incentive Plan (the

“Plan”) is to encourage and enable officers and employees of, and other persons providing services to, Cellectar Biosciences,

Inc. (the “Company”) and its Subsidiaries (as defined below) to acquire a proprietary interest in the Company. It is anticipated

that providing such persons with a direct stake in the Company’s welfare will assure a closer identification of their interests

with those of the Company and its stockholders, thereby stimulating their efforts on the Company’s behalf and strengthening their

desire to remain with the Company.

The following terms shall be defined as set forth

below:

“Award” or “Awards”, except

where referring to a particular category of grant under the Plan, shall include Incentive Stock Options, Non-Statutory Stock Options,

Restricted Stock Awards, Unrestricted Stock Awards, Performance Share Awards, Stock Appreciation Rights and Restricted Stock Units. Awards

shall be evidenced by a written agreement (which may be in electronic form and may be electronically acknowledged and accepted by the

recipient) containing such terms and conditions not inconsistent with the provisions of this Plan as the Committee shall determine.

“Board” means the Board of Directors

of the Company.

“Cause” shall mean, with respect to

any Award holder, a determination by the Company (including the Board) or any Subsidiary that the Holder’s employment or other relationship

with the Company or any such Subsidiary should be terminated as a result of (i) a material breach by the Award holder of any agreement

to which the Award holder and the Company (or any such Subsidiary) are parties, (ii) any act (other than retirement) or omission to act

by the Award holder that may have a material and adverse effect on the business of the Company, such Subsidiary or any other Subsidiary

or on the Award holder’s ability to perform services for the Company or any such Subsidiary, including, without limitation, the

proven or admitted commission of any crime (other than an ordinary traffic violation), or (iii) any material misconduct or material neglect

of duties by the Award holder in connection with the business or affairs of the Company or any such Subsidiary.

“Change of Control” shall have the

meaning set forth in Section 16.

“Code” means the Internal Revenue Code

of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.

“Committee” shall have the meaning

set forth in Section 2.

“Disability” means disability as set

forth in Section 22(e)(3) of the Code.

“Effective Date” shall mean March 4,

2021.

“Eligible Person” shall have the meaning

set forth in Section 4.

“Exchange Act” shall mean the Securities

Exchange Act of 1934, as amended.

“Fair Market Value” on any given date

means the closing price per share of the Stock on such date as reported by such registered national securities exchange on which the Stock

is listed, or, if the Stock is not listed on such an exchange, as quoted in the Over-the-Counter Market provided, that, if there is no

trading on such date, Fair Market Value shall be deemed to be the closing price per share on the last preceding date on which the Stock

was traded. If the Stock is not listed on any registered national securities exchange or quoted in the Over-the-Counter Market, the Fair

Market Value of the Stock shall be determined in good faith by the Committee.

“Incentive Stock Option” means any

Stock Option designated and qualified as an “incentive stock option” as defined in Section 422 of the Code.

“Non-Employee Director” means any director

who: (i) is not currently an officer of the Company or a Subsidiary, or otherwise currently employed by the Company or a Subsidiary, (ii)

does not receive compensation, either directly or indirectly, from the Company or a Subsidiary, for services rendered as a consultant

or in any capacity other than as a director, except for an amount that does not exceed the dollar amount for which disclosure would be

required pursuant to Rule 404(a) of Regulation S-K promulgated by the SEC, (iii) does not possess an interest in any other transaction

for which disclosure would be required pursuant to Rule 404(a) of Regulation S-K, (iv) is not engaged in a business relationship for which

disclosure would be required pursuant to Rule 404(b) of Regulation S-K and (v) otherwise meets the requirements under applicable law and

the stock exchange on which the Common Stock are then traded.

“Non-Statutory Stock Option” means

any Stock Option that is not an Incentive Stock Option.

“Option” or “Stock Option”

means any option to purchase shares of Stock granted pursuant to Section 5.

“Performance Goals” means, for a Performance

Period, the one or more goals established by the Committee for the Performance Period based upon business criteria or other performance

measures determined by the Committee in its discretion.

“Performance Period” means one or more

periods of time, which may be of varying and overlapping durations, as the Committee may select, over which the attainment of one or more

Performance Goals will be measured for the purpose of determining a recipient’s right to and the payment of a Performance-Based

Award granted pursuant to Section 11.

“Performance Share Award” means an

Award pursuant to Section 8.

“Restricted Stock Award” means an Award

granted pursuant to Section 6.

“Restricted Stock Unit” means an Award

granted pursuant to Section 10.

“SEC” means the Securities and Exchange

Commission or any successor authority.

“Section 409A” means Section 409A of

the Code and the regulations and other guidance promulgated thereunder.

“Stock” means the common stock, $0.00001

par value per share, of the Company, subject to adjustments pursuant to Section 3.

“Stock Appreciation Right” means an

Award granted pursuant to Section 9.

“Subsidiary” means any subsidiary corporation

of the Company, as defined in Section 424 of the Code.

“Termination Date” means the date,

as determined by the Committee, that an individual’s employment or service relationship, as applicable, with the Company or a Subsidiary

terminates for any reason.

“Unrestricted Stock Award” means Awards

granted pursuant to Section 7.

SECTION 2. Administration of Plan; Committee Authority to Select

Participants and Determine Awards.

(a) Committee. It is intended that the Plan

shall be administered by the Compensation Committee of the Board (the “Committee”), consisting of not less than two (2) persons

each of whom qualifies as a Non-Employee Director, but, except as required by law, the authority and validity of any act taken or not

taken by the Committee shall not be affected if any person administering the Plan is not a Non-Employee Director. Except as specifically

reserved to the Board under the terms of the Plan, and subject to any limitations set forth in the charter of the Committee, the Committee

shall have full and final authority to operate, manage and administer the Plan on behalf of the Company.

(b) Powers of Committee. The Committee shall

have the power and authority to grant and modify Awards consistent with the terms of the Plan, including the power and authority:

(i) to select the persons to whom Awards may from

time to time be granted;

(ii) to determine the time or times of grant, and

the extent, if any, of Incentive Stock Options, Non-Statutory Stock Options, Restricted Stock, Unrestricted Stock, Performance Shares

and Stock Appreciation Rights, or any combination of the foregoing, granted to any one or more participants;

(iii) to determine the number of shares to be covered

by any Award;

(iv) to determine and modify the terms and conditions,

including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual

Awards and participants, and to approve the form of written instruments evidencing the Awards, except that repricing of Stock Options

and Stock Appreciation Right and a cash buyout of underwater Stock Options for cash shall not be permitted without stockholder approval;

provided, however, that that if any such amendment impairs a Participant’s rights or increases a Participant’s obligations

under his or her Award or creates or increases a Participant’s federal income tax liability with respect to an Award, such amendment

shall also be subject to the Participant’s consent;

(v) to accelerate the exercisability or vesting of

all or any portion of any Award;

(vi) to extend the period in which any outstanding

Stock Option or Stock Appreciation Right may be exercised; and

(vii) to adopt, alter and repeal such rules, guidelines

and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and

provisions of the Plan and any Award (including related written instruments); to make all determinations it deems advisable for the administration

of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise supervise the administration of the Plan.

All decisions and interpretations of the Committee

shall be binding on all persons, including the Company and Plan participants. No member or former member of the Committee or the Board

shall be liable for any action or determination made in good faith with respect to this Plan.

SECTION 3. Shares Issuable under the Plan; Mergers; Substitution.

(a) Shares Issuable. The maximum number

of shares of Stock which may be issued in respect of Awards (including Stock Appreciation Rights) granted under the Plan, subject to adjustment

upon changes in capitalization of the Company as provided in this Section 3, shall be 2,306,666 shares, plus an additional number of shares,

that are currently available under the Company’s Amended and Restated 2015 Stock Incentive Plan (the “2015 Plan”) Amended

and Restated 2006 Stock Incentive Plan (the “2006 Plan”) or may be added back to the Plan pursuant to the next sentence, in

each case subject to adjustment upon changes in capitalization of the Company as provided in this Section 3. All of the shares described

in the previous sentence may be granted as Incentive Stock Options. For purposes of this limitation, the shares of Stock underlying any

Awards, or awards under the 2015 Plan or 2006 Plan, as applicable, which are forfeited, cancelled, reacquired by the Company or otherwise

terminated (other than (i) Shares tendered as payment for an option exercise; (ii) Shares withheld to cover taxes; (iii) Shares added

back that have been repurchased by the Company using stock option proceeds; and (iv) stock-settled awards where only the actual shares

delivered count against the Plan) shall be added back to the shares of Stock with respect to which Awards may be granted under the Plan.

Shares issued under the Plan may be authorized but unissued shares or shares reacquired by the Company.

(b) Change in Stock. Subject to Section

16 hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split

or other similar change in the Company’s capital stock, the outstanding shares of Stock are increased or decreased or are exchanged

for a different number or kind of shares or other securities of the Company, or additional shares or new or different shares or other

securities of the Company or other non-cash assets are distributed with respect to such shares of Stock or other securities, or, if, as

a result of any merger or consolidation, sale of all or substantially all of the assets of the Company, the outstanding shares of Stock

are converted into or exchanged for a different number or kind of securities of the Company or any successor entity (or a parent or subsidiary

thereof), the Committee shall make an appropriate or proportionate adjustment in (i) the maximum number of shares reserved for issuance

under the Plan, (ii) the number of shares of Stock that can be granted to any one individual recipient, (iii) the maximum number of shares

that may be granted under a Performance-Based Award, (iv) the number and kind of shares or other securities subject to any then outstanding

Awards under the Plan, (v) the repurchase price per share subject to each outstanding Restricted Stock Award, and (vi) the price for each

share subject to any then outstanding Stock Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise

price (i.e., the exercise price multiplied by the number of Stock Options or Stock Appreciation Rights) as to which such Stock Options

and Stock Appreciation Rights remain exercisable. The adjustment by the Committee shall be final, binding and conclusive. No fractional

shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash

payment in lieu of fractional shares.

grant Awards under the Plan in substitution for stock and stock based awards held by employees of another corporation who concurrently

become employees of the Company or a Subsidiary as the result of a merger or consolidation of the employing corporation with the Company

or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the employing corporation. The Committee may

direct that the substitute awards be granted on such terms and conditions as the Committee considers appropriate in the circumstances.

Any substitute Awards granted under the Plan shall not count against the share limitation applicable to individuals set forth in the penultimate

sentence of Section 3(a).

SECTION 4. Eligibility.

Incentive Stock Options may be granted to employees

(including officer and directors who are also employees) of the Company or a Subsidiary, and all other Awards may be granted to officers,

directors and employees of, and consultants and advisers to, the Company and its Subsidiaries (all such persons, “Eligible Persons”).

SECTION 5. Stock Options.

Any Stock Option granted under the Plan shall be

in such form as the Committee may from time to time approve.

Stock Options granted under the Plan may be either

Incentive Stock Options (subject to compliance with applicable law) or Non-Statutory Stock Options. Unless otherwise so designated, an

Option shall be a Non-Statutory Stock Option. To the extent that any option does not qualify as an Incentive Stock Option, it shall constitute

a Non-Statutory Stock Option.

No Incentive Stock Option shall be granted under

the Plan after the tenth anniversary of the date of adoption of the Plan by the Board.

Stock Options granted pursuant to this Section

5 shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable.

(a) Exercise Price. The exercise price per

share for the Stock covered by a Stock Option granted pursuant to this Section 5 shall be determined by the Committee at the time of grant

but shall be not less than one hundred percent (100%) of Fair Market Value on the date of grant. If an employee owns or is deemed to own

(by reason of the attribution rules applicable under Section 424(d) of the Code) more than ten percent (10%) of the combined voting power

of all classes of stock of the Company or any subsidiary or parent corporation and an Incentive Stock Option is granted to such employee,

the option price shall be not less than one hundred ten percent (110%) of Fair Market Value on the date of grant.

(b) Option Term. The term of each Stock

Option shall be fixed by the Committee, but no Stock Option shall be exercisable more than ten (10) years after the date the option is

granted. If an employee owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than ten percent

(10%) of the combined voting power of all classes of stock of the Company or any subsidiary or parent corporation and an Incentive Stock

Option is granted to such employee, the term of such option shall be no more than five (5) years from the date of grant.

Stock Options shall become vested and exercisable at such time or times, whether or not in installments, as shall be determined by the

Committee. The Committee may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have

the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options.

(d) Method of Exercise. Stock Options may

be exercised in whole or in part, by delivering written notice of exercise to the Company, specifying the number of shares to be purchased.

Payment of the purchase price may be made by delivery of cash or bank check or other instrument acceptable to the Committee in an amount

equal to the exercise price of such Options, or, to the extent provided in the applicable Option Agreement, by one or more of the following

methods:

(i) by delivery to the Company of (or attestation

to the ownership of) shares of Stock, not subject to restrictions under any Company plan, having a Fair Market Value equal in amount to

the aggregate exercise price of the Options being exercised; or

(ii) if the class of Stock is registered under the

Exchange Act at such time, by delivery to the Company of a properly executed exercise notice along with irrevocable instructions to a

broker to deliver promptly to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that

in the event that the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures

and enter into such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure

(including, in the case of an optionee who is an executive officer of the Company, such procedures and agreements as the Committee deems

appropriate in order to avoid any extension of credit in the form of a personal loan to such officer). The Company need not act upon such

exercise notice until the Company receives full payment of the exercise price; or

(iii) by reducing the number of Option shares otherwise

issuable to the optionee upon exercise of the Option by a number of shares of Common Stock having a Fair Market Value equal to such aggregate

exercise price of the Options being exercised; or

(iv) by any combination of such methods of payment.

The delivery of certificates representing shares

of Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser

acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such shares and

the fulfillment of any other requirements contained in the Stock Option or imposed by applicable law.

(e) Non-transferability of Options. Except

as the Committee may provide with respect to a Non-Statutory Stock Option, no Stock Option shall be transferable other than by will or

by the laws of descent and distribution and all Stock Options shall be exercisable, during the optionee’s lifetime, only by the

optionee.

(f) Annual Limit on Incentive Stock Options.

To the extent required for “incentive stock option” treatment under Section 422 of the Code, the aggregate Fair Market Value

(determined as of the time of grant) of the Stock with respect to which Incentive Stock Options granted under this Plan and any other

plan of the Company or its Subsidiaries become exercisable for the first time by an optionee during any calendar year shall not exceed

$100,000.

(g) Exercise Period following Termination.

When an optionee’s employment (or other service relationship) with the Company and its Subsidiaries terminates, the optionee’s

Stock Options may be exercised within the period of time specified in the agreement evidencing the Option, to the extent that the Option

is vested on the optionee’s Termination Date. In the absence of a specific period of time set forth in such agreement, Stock Options

shall remain exercisable (to the extent vested on the optionee’s Termination Date): (i) for 90 days following the Termination Date

upon retirement or any termination by us without cause; or (ii) for 30 days following voluntary termination by the optionee; or (iii)

for 90 days following the Disability of the optionee; or (iv) for 180 days following the Termination Date upon termination for death;

provided however that in no event shall any Option be exercisable after the expiration of the term of such Option; and provided further

that in the event that an optionee’s employment with the Company or a Subsidiary has been terminated by the Company for Cause, as

determined by the Committee in its sole discretion, any Stock Option held by such optionee shall immediately terminate and be of no further

force and effect.

(h) No Dividend Rights. Prior to exercise,

Stock Options shall not have a right to receive dividend payments or dividend equivalent payments.

SECTION 6. Restricted Stock Awards.

(a) Nature of Restricted Stock Award. The

Committee in its discretion may grant Restricted Stock Awards to any Eligible Person, entitling the recipient to acquire, for such purchase

price, if any, as may be determined by the Committee, shares of Stock subject to such restrictions and conditions as the Committee may

determine at the time of grant (“Restricted Stock”), including continued employment and/or achievement of pre-established

performance goals and objectives.

(b) Acceptance of Award. A participant who

is granted a Restricted Stock Award shall have no rights with respect to such Award unless the participant shall have accepted the Award

within sixty (60) days (or such shorter date as the Committee may specify) following the award date by making payment to the Company of

the specified purchase price, if any, of the shares covered by the Award and by executing and delivering to the Company a written instrument

that sets forth the terms and conditions applicable to the Restricted Stock in such form as the Committee shall determine.

with Section 6(b) above, a participant shall have all the rights of a stockholder with respect to the Restricted Stock, including voting

rights, subject to non-transferability restrictions and Company repurchase or forfeiture rights described in this Section 6 and subject

to such other conditions contained in the written instrument evidencing the Restricted Award. Unless the Committee shall otherwise determine,

certificates evidencing shares of Restricted Stock Award shall remain in the possession of the Company until such shares are vested as

provided in Section 6(e) below.

(d) Restrictions. Shares of Restricted Stock

may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein. In the

event of termination of employment by the Company and its Subsidiaries for any reason (including death, Disability, Normal Retirement

and for Cause), any shares of Restricted Stock which have not then vested shall automatically be forfeited to the Company.

(e) Vesting of Restricted Stock. The Committee

at the time of grant shall specify the date or dates and/or the attainment of pre-established performance goals, objectives and other

conditions on which the non-transferability of the Restricted Stock and the Company’s right of forfeiture shall lapse. Subsequent

to such date or dates and/or the attainment of such pre-established performance goals, objectives and other conditions, the shares on

which all restrictions have lapsed shall no longer be Restricted Stock and shall be deemed “vested.” The Committee at any

time may accelerate such date or dates and otherwise waive or, subject to Section 14, amend any conditions of the Award.

(f) No Dividend Rights. Unvested shares

of Restricted Stock shall not have a right to receive dividend payments or dividend equivalent payments with respect to unvested shares

of Restricted Stock.

SECTION 7. Unrestricted Stock Awards.

(a) Grant or Sale of Unrestricted Stock.

The Committee in its discretion may grant or sell to any Eligible Person shares of Stock free of any restrictions under the Plan (“Unrestricted

Stock”) at a purchase price determined by the Committee. Shares of Unrestricted Stock may be granted or sold as described in the

preceding sentence in respect of past services or other valid consideration.

(b) Restrictions on Transfers. The right

to receive unrestricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered, other than by will or the laws

of descent and distribution.

SECTION 8. Performance Share Awards.

A Performance Share Award is an award entitling

the recipient to acquire shares of Stock upon the attainment of specified Performance Goals; provided however that the Committee, in its

discretion, may provide either at the time of grant or at the time of settlement that a Performance Share Award will be settled in cash.

The Committee may make Performance Share Awards independent of or in connection with the granting of any other Award under the Plan. Performance

Share Awards may be granted under the Plan to any Eligible Person. The Committee in its discretion shall determine whether and to whom

Performance Share Awards shall be made, the performance goals applicable under each such Award (which may include, without limitation,

continued employment by the recipient or a specified achievement by the recipient, the Company or any business unit of the Company), the

periods during which performance is to be measured, and all other limitations and conditions applicable to the Award or the Stock issuable

thereunder. Upon the attainment of the specified performance goal shares of Stock (or cash, as applicable) shall be issued pursuant to

the Performance Share Award as soon as practicable thereafter, but in no event later than two and one-half months after the calendar year

in which such performance goal is attained.

SECTION 9. Stock Appreciation Rights.

The Committee in its discretion may grant Stock

Appreciation Rights to any Eligible Person. A Stock Appreciation Right shall entitle the participant upon exercise thereof to receive

from the Company, upon written request to the Company at its principal offices (the “Request”), a number of shares of Stock,

a cash payment, or a combination of shares and cash (as provided in the Stock Appreciation Right) having an aggregate Fair Market Value

equal to the product of (a) the excess of Fair Market Value, on the date of such Request, over the exercise price per share of Stock specified

in such Stock Appreciation Right (which exercise price shall be not less than one hundred percent (100%) of Fair Market Value on the date

of grant), multiplied by (b) the number of shares of Stock for which such Stock Appreciation Right shall be exercised. Any Stock Appreciation

Right granted under the Plan shall contain such terms and conditions with respect to its termination as the Committee, in its discretion,

may from time to time determine; provided however that the term of a Stock Appreciation Right shall not exceed ten years. Stock Appreciation

Fights shall not have a right to receive dividend payments or dividend equivalent payments.

SECTION 10. Restricted Stock Units.

A Restricted Stock Unit is a bookkeeping entry

representing the right to receive, upon its vesting, one share of Stock (or a percentage or multiple of one share of Stock if so specified

in the agreement evidencing the Award) for each Restricted Stock Unit awarded to a recipient and represents an unfunded and unsecured

obligation of the Company. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Unit at the

time of grant. Conditions may be based on continuing employment (or other service relationship) and/or achievement of pre-established

performance goals and objectives. At the end of the vesting period, the Restricted Stock Units, to the extent vested, shall be settled

in the form of shares of Stock. Notwithstanding the foregoing, the Committee, in its discretion, may determine either at the time of grant

or at the time of settlement, that a Restricted Stock Unit shall be settled in cash. Except to the extent that the Committee provides

otherwise, a recipient’s right in all Restricted Stock Units that have not vested shall automatically terminate immediately following

the recipient’s termination of employment (or cessation of service relationship) with the Company and its Subsidiaries. Restricted

Stock Units shall not have a right to receive dividend payments or dividend equivalent payments with respect to unvested shares of Restricted

Stock Units.

SECTION 11. Performance-Based Awards.

(a) Performance-Based Awards. A Performance-Based

Award shall be payable upon the attainment of Performance Goals that are established by the Committee, in each case on a specified date

or dates or over any period or periods determined by the Committee. The Committee shall define in an objective fashion the manner of calculating

the Performance Goals it selects to use for any Performance Period. The Committee, in its discretion, may adjust or modify the calculation

of Performance Goals for such Performance Period in order to prevent the dilution or enlargement of the rights of an individual (i) in

the event of, or in anticipation of, any unusual or extraordinary corporate item, transaction, event or development, (ii) in recognition

of, or in anticipation of, any other unusual or nonrecurring events affecting the Company, or the financial statements of the Company,

or (iii) in response to, or in anticipation of, changes in applicable laws, regulations, accounting principles, or business conditions;

provided, however, that the Committee may not exercise such discretion in a manner that would increase the amount of the Performance-Based

Award.

(b) Grant of Performance-Based Awards. With

respect to each Performance-Based Award, the Committee shall select the Performance Goals for such grant (including a threshold level

of performance below which no amount will become payable with respect to such Award). Each Performance-Based Award will specify the amount

payable, or the formula for determining the amount payable, upon achievement of the various applicable Performance Goals.

the completion of a Performance Period, the Committee shall review and certify in writing whether, and to what extent, the Performance

Goals for the Performance Period have been achieved and, if so, shall calculate and certify in writing the amount of the Performance-Based

Awards earned for the Performance Period. The Committee shall then determine the actual size of each recipient’s Performance-Based

Award, and, in doing so, may reduce (but not increase) or eliminate the amount of the Performance-Based Award if, in its sole judgment,

such reduction or elimination is appropriate.

(d) No Dividend Rights. Performance-Based

Awards shall not have a right to receive dividend payments or dividend equivalent payments.

SECTION 12. Tax Withholding.

(a) Payment by Participant. Each participant

shall, no later than the date as of which the value of an Award or of any Stock or other amounts received thereunder first becomes includable

in the gross income of the participant for Federal income tax purposes, pay to the Company, or make arrangements satisfactory to the Committee

regarding payment of any Federal, state, local and/or payroll taxes of any kind required by law to be withheld with respect to such income.

The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any

kind otherwise due to the participant.

(b) Payment in Shares. The

Committee may provide, in an award agreement, that the Participant may direct the Company to satisfy such Participant’s tax withholding

obligations through the withholding of Shares otherwise to be acquired upon the exercise or payment of such Award; provided, that,

in such case, the number of Shares that shall be so withheld shall be limited to the number of Shares having an aggregate Fair Market

Value on the date of withholding equal to the aggregate amount of such tax withholding obligations determined based on an amount that

is up to the applicable maximum statutory tax withholding requirements; provided, that the exercise of such discretion by the Committee

would not cause an Award otherwise classified as an equity award under ASC Topic 718 to be classified as a liability award under ASC Topic

718.

any provision of this Plan, each Participant is solely responsible and liable for the satisfaction of all taxes and penalties of any kind

and with respect to any tax jurisdiction that may be imposed on or for the account of such Participant in connection with the Plan.

SECTION 13. Transfer and Leave of Absence.

For purposes of the Plan, the following events

shall not be deemed a termination of employment:

(a) a transfer to the employment of the Company

from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another;

(b) an approved leave of absence for military service

or sickness, or for any other purpose approved by the Company, if the employee’s right to re-employment is guaranteed either by

a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides

in writing; provided, that the vesting date or dates of any unvested Award held by such employee shall automatically be extended by a

period of time equal to the period of such approved leave of absence.

SECTION 14. Amendments and Termination.

The Board may at any time amend or discontinue

the Plan and the Committee may at any time amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any

other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the holder’s consent.

Notwithstanding the foregoing, neither the Board nor the Committee shall have the power or authority to decrease the exercise price of

any outstanding Stock Option or Stock Appreciation Right, whether through amendment, cancellation and regrant, exchange or any other means,

except for changes made pursuant to Section 3(b).

This Plan shall terminate as of the tenth anniversary

of its Effective Date. The Board may terminate this Plan at any earlier time for any reason. No Award may be granted after the Plan has

been terminated. No Award granted while this Plan is in effect shall be adversely altered or impaired by termination of this Plan, except

upon the consent of the holder of such Award. The power of the Committee to construe and interpret this Plan and the Awards granted prior

to the termination of this Plan shall continue after such termination.

SECTION 15. Status of Plan.

With respect to the portion of any Award which

has not been exercised and any payments in cash, Stock or other consideration not received by a participant, a participant shall have

no rights greater than those of a general creditor of the Company unless the Committee shall otherwise expressly determine in connection

with any Award or Awards.

SECTION 16. Change of Control Provisions.

(a) Upon the occurrence of a Change of Control

as defined in this Section 16, the Committee in its discretion may, at the time an Award is made or at any time thereafter, take one or

more of the following actions: (i) provide for the acceleration of any time period relating to the exercise or payment of the Award; (ii)

provide for termination of any Awards not exercised prior to the occurrence of a Change in Control; (iii) provide for payment to the holder

of the Award of cash or other property with a Fair Market Value equal to the amount that would have been received upon the exercise or

payment of the Award had the Award been exercised or paid upon the Change in Control in exchange for cancellation of the Award; (iv) adjust

the terms of the Award in a manner determined by the Committee to reflect the Change in Control; (v) cause the Award to be assumed, or

new rights substituted therefor, by another entity; or (vi) make such other provision as the Committee may consider equitable to the holders

of Awards and in the best interests of the Company.

(b) “Change of Control” shall

mean: (a) with respect to an Award that is subject to section 409A of the Code, the occurrence of any event which constitutes a change

of control under section 409A of the Code, including any regulations promulgated pursuant thereto; and (b) with respect to any other Award,

the occurrence of any of the following events:

(i) any “person” (as such term is used

in Sections 13(d) and 14(d)(2) of the Exchange Act) becomes, after the Effective Date of this Plan, a “beneficial owner” (as

such term is defined in Rule 13d-3 promulgated under the Exchange Act) (other than the Company, any trustee or other fiduciary holding

securities under an employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the

Company in substantially the same proportions as their ownership of stock of the Company), directly or indirectly, of securities of the

Company representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities; or

(ii) the consummation of a merger or consolidation

of the Company with any other corporation or other entity, other than a merger or consolidation which would result in the voting securities

of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into

voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the

Company or such surviving entity outstanding immediately after such merger or consolidation; or

(iii) the closing of a sale or other disposition

by the Company of all or substantially all of the assets of the Company;

(iv) individuals who constitute the Board on the

Effective Date (“Incumbent Directors”) cease for any reason to constitute at least a majority of the Board; provided,

that any individual who becomes a member of the Board subsequent to the Effective Date, whose election or nomination for election was

approved by a vote of at least two-thirds of the Incumbent Directors shall be treated as an Incumbent Director unless he or she assumed

office as a result of an actual or threatened election contest with respect to the election or removal of directors; or

(v) a complete liquidation or dissolution

of the Company.

SECTION 17. General Provisions.

(a) No Distribution; Compliance with Legal Requirements.

The Committee may require each person acquiring shares pursuant to an Award to represent to and agree with the Company in writing that

such person is acquiring the shares without a view to distribution thereof.

No shares of Stock shall be issued pursuant to

an Award until all applicable securities laws and other legal and stock exchange requirements have been satisfied. The Committee may require

the placing of such stop orders and restrictive legends on certificates for Stock and Awards as it deems appropriate.

No Award under the Plan shall be a nonqualified

deferred compensation plan, as defined in Code Section 409A, unless such Award meets in form and in operation the requirements of Code

Section 409A(a)(2),(3), and (4).

Notwithstanding anything to the contrary contained

in this Plan, Awards may be made to an individual who is a foreign national or employed or performing services outside of the United States

on such terms and conditions different from those specified in the Plan as the Committee considers necessary or advisable to achieve the

purposes of the Plan or to comply with applicable laws.

(b) Delivery of Stock Certificates. Delivery

of stock certificates to participants under this Plan shall be deemed effected for all purposes when the Company or a stock transfer agent

of the Company shall have delivered such certificates in the United States mail, addressed to the participant, at the participant’s

last known address on file with the Company. In lieu of delivery of stock certificates, the Company may, to the extent permitted by law

and the Certificate of Incorporation and by-laws of the Company, issue shares of Stock hereunder in book entry form.

Rights. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, including

trusts, subject to stockholder approval if such approval is required; and such arrangements may be either generally applicable or applicable

only in specific cases. The adoption of the Plan or any Award under the Plan does not confer upon any employee any right to continued

employment with the Company or any Subsidiary.

(d) Trading Policy Restrictions. Option

exercises and other Awards under the Plan shall be subject to the Company’s insider trading policy, as in effect from time to time.

(e) Lock-Up Agreement. By accepting any

Award, the recipient shall be deemed to have agreed that, if so requested by the Company or by the underwriters managing any underwritten

offering of the Company’s securities, the recipient will not, without the prior written consent of the Company or such underwriters,

as the case may be, sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any shares subject

to any such Award during the Lock-up Period, as defined below. The “Lock-Up Period” shall mean a period of time not exceeding

180 days or, if greater, such number of days as shall have been agreed to by each director and executive officer of the Company in connection

with such offering in a substantially similar lock-up agreement by which each such director and executive officer is bound. If requested

by the Company or such underwriters, the recipient shall enter into an agreement with such underwriters consistent with the foregoing.

(f) Section 409A Awards. The Plan is intended

to comply with Section 409A of the Code to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall

be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term

deferral period” as defined in Section 409A of the Code shall not be treated as deferred compensation unless Applicable Laws require

otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties

under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the

Plan during the six (6) month period immediately following the Participant’s termination of Continuous Service shall instead be

paid on the first payroll date after the six-month anniversary of the Participant’s separation from service (or the Participant’s

death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any obligation to take any action

to prevent the assessment of any additional tax or penalty on any Participant under Section 409A of the Code and neither the Company nor

the Committee will have any liability to any Participant for such tax or penalty.

(g) Section 16. It is the intent of the

Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of Rule 16b-3 as promulgated

under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of Rule 16b-3, or any other rule promulgated

under Section 16 of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly,

if the operation of any provision of the Plan would conflict with the intent expressed in this Section 17(g), such provision to the extent

possible shall be interpreted and/or deemed amended so as to avoid such conflict.

(h) No

Fractional Shares. No fractional shares of Common Stock shall be issued or delivered pursuant to the Plan. The Committee shall determine

whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional shares of Common Stock or

whether any fractional shares should be rounded, forfeited or otherwise eliminated.

SECTION 18. Effective Date.

The Plan is effective as of March 4, 2021, subject

to approval by the holders of a majority of the shares of stock of the Company present or represented and entitled to vote at a meeting

of stockholders at which a quorum is present or by written consent of the stockholders.

SECTION 19. Governing Law.

This Plan shall be governed by, and construed and

enforced in accordance with, the substantive laws of the State of Delaware without regard to its principles of conflicts of laws.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Jul. 07, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 07, 2026

Entity File Number

1-36598

Entity Registrant Name

Cellectar Biosciences, Inc.

Entity Central Index Key

0001279704

Entity Tax Identification Number

04-3321804

Entity Incorporation, State or Country Code

Entity Address, Address Line One

100

Campus Drive

Entity Address, City or Town

Florham Park

Entity Address, State or Province

Entity Address, Postal Zip Code

07932

City Area Code

608

Local Phone Number

441-8120

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, par value $0.00001 per share

Trading Symbol

CLRB

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration